ArticleFrontiers in oncology2022

A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung Cancer.

Chiara Gargiuli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.